PMID- 28800733 OWN - NLM STAT- MEDLINE DCOM- 20180108 LR - 20190115 IS - 1471-2261 (Electronic) IS - 1471-2261 (Linking) VI - 17 IP - 1 DP - 2017 Aug 11 TI - Integrative and quantitive evaluation of the efficacy of his bundle related pacing in comparison with conventional right ventricular pacing: a meta-analysis. PG - 221 LID - 10.1186/s12872-017-0649-4 [doi] LID - 221 AB - BACKGROUND: Long-term RVP could bring adverse problems to cardiac electro-mechanics and result in inter- and intra-ventricular asynchrony, impaired labor force, and aggravation of cardiac function. HBRP including direct His bundle pacing and para-His bundle pacing was regarded as a novel physiological pacing pattern to avoid devastating cardiac function. This synthetic study was conducted to integratively and quantitatively evaluate the efficacy of His bundle related pacing (HBRP) in comparison with conventional right ventricular pacing (RVP). METHODS: Published studies on comparison of left ventricular ejection fraction (LVEF), left ventricular end diastolic volume (LVEDV), left ventricular end systolic volume (LVESV), New York Heart Association (NYHA) class, inter-ventricular asynchrony, and QRS duration, etc. between HBRP and RVP were collected and for meta-analysis. RESULTS: HBRP showed higher LVEF (WMD = 3.9%, 95% CI: 1.6% - 6.1%), lower NYHA class (WMD = -0.5, 95% CI: -0.7 - -0.3), WMD of LVESV = -0.1 ml, 95% CI: -3.0 - 2.8 ml), less inter-ventricular asynchrony (WMD = -13.2 ms, 95% CI: -16.4 - -10.0 ms), and shorter QRS duration for long-term (WMD = -36.9 ms, 95% CI: -40.0 - -33.8 ms), however, no significant difference of ventricular volume (WMDLVEDV = -2.4 ml, 95% CI: -5.0 - 0.2 ml; WMDLVESV = -0.1 ml, 95% CI: -3.0 - 2.8 ml) compared to RVP. CONCLUSIONS: The efficacy of HBRP was firstly verified by meta-analysis to date. Compared with RVP, HBRP markedly preserve LVEF, NYHA class, and QRS duration. However, it seemed to have less effect on ventricular volume. FAU - Yu, Ziqing AU - Yu Z AD - Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. AD - Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China. FAU - Chen, Ruizhen AU - Chen R AD - Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. AD - Key Laboratory of Viral Heart Diseases, Ministry of Public Health, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. FAU - Su, Yangang AU - Su Y AD - Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. su.yangang@zs-hospital.sh.cn. FAU - Chen, Xueying AU - Chen X AD - Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. FAU - Qin, Shengmei AU - Qin S AD - Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. FAU - Li, Minghui AU - Li M AD - Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. AD - Key Laboratory of Viral Heart Diseases, Ministry of Public Health, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. FAU - Han, Fei AU - Han F AD - Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. AD - Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China. FAU - Ge, Junbo AU - Ge J AUID- ORCID: 0000-0002-6655-1337 AD - Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. ge.junbo@zs-hospital.sh.cn. LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20170811 PL - England TA - BMC Cardiovasc Disord JT - BMC cardiovascular disorders JID - 100968539 SB - IM MH - Action Potentials MH - Aged MH - Aged, 80 and over MH - Bradycardia/physiopathology/*therapy MH - Bundle of His/*physiopathology MH - Cardiac Pacing, Artificial/*methods MH - Female MH - *Heart Rate MH - Heart Ventricles/*physiopathology MH - Humans MH - Male MH - Middle Aged MH - Stroke Volume MH - Time Factors MH - Ventricular Function, Left MH - *Ventricular Function, Right PMC - PMC5553603 OTO - NOTNLM OT - Cardiac function OT - His bundle pacing OT - Left ventricular ejection fraction OT - Meta-analysis OT - Right ventricular pacing OT - para-his bundle pacing COIS- ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT TO PUBLISH: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interest. PUBLISHER'S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2017/08/13 06:00 MHDA- 2018/01/09 06:00 PMCR- 2017/08/11 CRDT- 2017/08/13 06:00 PHST- 2017/03/24 00:00 [received] PHST- 2017/07/27 00:00 [accepted] PHST- 2017/08/13 06:00 [entrez] PHST- 2017/08/13 06:00 [pubmed] PHST- 2018/01/09 06:00 [medline] PHST- 2017/08/11 00:00 [pmc-release] AID - 10.1186/s12872-017-0649-4 [pii] AID - 649 [pii] AID - 10.1186/s12872-017-0649-4 [doi] PST - epublish SO - BMC Cardiovasc Disord. 2017 Aug 11;17(1):221. doi: 10.1186/s12872-017-0649-4.